Universal Electronics (UEIC) 10-Q 8 May 15 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2015	5-May-15
Document and Entity Information [Abstract]
Entity Registrant Name	UNIVERSAL ELECTRONICS INC
Entity Central Index Key	101984
Document Type	10-Q
Document Period End Date	31-Mar-15
Amendment Flag	FALSE
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	-19
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		15,864,518

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Current assets:
Cash and cash equivalents	$97,102	$112,521
Accounts receivable, net	93,808	97,989
Inventories, net	100,181	97,474
Prepaid expenses and other current assets	5,817	6,856
Income tax receivable	69	77
Deferred income taxes	5,203	5,048
Total current assets	302,180	319,965
Property, plant, and equipment, net	79,149	76,135
Goodwill	30,525	30,739
Intangible assets, net	24,225	24,614
Deferred income taxes	6,802	6,146
Other assets	5,682	5,471
Total assets	448,563	463,070
Current liabilities:
Accounts payable	64,201	69,991
Line of credit	0	0
Accrued compensation	34,219	40,656
Accrued sales discounts, rebates and royalties	6,770	8,097
Accrued income taxes	3,446	4,263
Deferred income taxes	0	0
Other accrued expenses	12,406	13,358
Total current liabilities	121,042	136,365
Long-term liabilities:
Deferred income taxes	8,474	8,456
Income tax payable	566	566
Other long-term liabilities	2,044	2,062
Total liabilities	132,126	147,449
Commitments and contingencies
Stockholders' equity:
Preferred stock, $0.01 par value, 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock, $0.01 par value, 50,000,000 shares authorized; 22,992,947 and 22,909,884 shares issued on March 31, 2015 and December 31, 2014, respectively	230	229
Paid-in capital	218,615	214,710
Accumulated other comprehensive income (loss)	-8,704	-4,446
Retained earnings	231,255	226,066
Stockholders' equity before treasury stock	441,396	436,559
Less cost of common stock in treasury, 7,077,935 and 7,008,475 shares on March 31, 2015 and December 31, 2014, respectively	-124,959	-120,938
Total stockholders' equity	316,437	315,621
Total liabilities and stockholders' equity	$448,563	$463,070

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Preferred stock, par value	$0.01	$0.01
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$0.01	$0.01
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	22,992,947	22,909,884
Treasury stock, shares	7,077,935	7,008,475

CONSOLIDATED_INCOME_STATEMENTS

CONSOLIDATED INCOME STATEMENTS (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Income Statement [Abstract]
Net sales	$132,705	$129,845
Cost of sales	95,296	93,299
Gross profit	37,409	36,546
Research and development expenses	4,434	4,277
Selling, general and administrative expenses	26,872	26,279
Operating income	6,103	5,990
Interest income (expense), net	110	-16
Other income (expense), net	230	-349
Income before provision for income taxes	6,443	5,625
Provision for income taxes	1,254	1,352
Net income	$5,189	$4,273
Earnings per share:
Basic (in dollars per share)	$0.33	$0.27
Diluted (in dollars per share)	$0.32	$0.26
Shares used in computing earnings per share:
Basic (in shares)	15,907	15,787
Diluted (in shares)	16,243	16,163

CONSOLIDATED_COMPREHENSIVE_INC

CONSOLIDATED COMPREHENSIVE INCOME STATEMENTS (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Statement of Comprehensive Income [Abstract]
Net income	$5,189	$4,273
Other comprehensive income (loss):
Change in foreign currency translation adjustment	-4,258	-2,111
Comprehensive income (loss)	$931	$2,162

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Cash provided by (used for) operating activities:
Net income	$5,189	$4,273
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
Depreciation and amortization	4,667	4,260
Provision for doubtful accounts	2	61
Provision for inventory write-downs	906	596
Deferred income taxes	-806	948
Tax benefit from exercise of stock options and vested restricted stock	567	731
Excess tax benefit from stock-based compensation	-587	-723
Shares issued for employee benefit plan	391	347
Stock-based compensation	1,959	1,678
Changes in operating assets and liabilities:
Accounts receivable	342	9,967
Inventories	-5,993	4,756
Prepaid expenses and other assets	755	-15
Accounts payable and accrued expenses	-12,209	-10,489
Accrued income taxes	-832	-2,484
Net cash provided by (used for) operating activities	-5,649	13,906
Cash used for investing activities:
Acquisition of property, plant, and equipment	-7,210	-2,396
Acquisition of intangible assets	-681	-204
Net cash used for investing activities	-7,891	-2,600
Cash provided by (used for) financing activities:
Proceeds from stock options exercised	989	3,272
Treasury stock purchased	-4,021	-405
Excess tax benefit from stock-based compensation	587	723
Net cash provided by (used for) financing activities	-2,445	3,590
Effect of exchange rate changes on cash	566	-670
Net increase (decrease) in cash and cash equivalents	-15,419	14,226
Cash and cash equivalents at beginning of year	112,521	76,174
Cash and cash equivalents at end of period	97,102	90,400
Supplemental Cash Flow Information:
Income taxes paid	$2,000	$1,601

Basis_of_Presentation_and_Sign

Basis of Presentation and Significant Accounting Policies	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Basis of Presentation and Significant Accounting Policies	Basis of Presentation and Significant Accounting Policies
	In the opinion of management, the accompanying consolidated financial statements of Universal Electronics Inc. and its wholly-owned subsidiaries contain all the adjustments necessary for a fair presentation of financial position, results of operations and cash flows for the periods presented. All such adjustments are of a normal recurring nature and certain reclassifications have been made to prior year amounts in order to conform to the current year presentation. Information and footnote disclosures normally included in financial statements, which are prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"), have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission. As used herein, the terms "Company," "we," "us," and "our" refer to Universal Electronics Inc. and its subsidiaries, unless the context indicates to the contrary.
	Our results of operations for the three months ended March 31, 2015 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations," "Quantitative and Qualitative Disclosures About Market Risk," and the "Financial Statements and Supplementary Data" and notes thereto included in Items 1A, 7, 7A, and 8, respectively, of our Annual Report on Form 10-K for the year ended December 31, 2014.
	Estimates, Judgments and Assumptions
	The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an on-going basis, we evaluate our estimates and assumptions, including those related to revenue recognition, allowances for sales returns and doubtful accounts, inventory valuation, our review of impairment of long-lived assets, intangible assets and goodwill, income taxes and stock-based compensation expense. Actual results may differ from these estimates and assumptions, and they may be adjusted as more information becomes available. Any adjustment may be material.
	See Note 2 to the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2014 for a summary of our significant accounting policies.
	Recent Accounting Pronouncements
	In May 2014, the FASB issued ASU 2014-09, "Revenue from Contracts with Customers", which will supersede most existing U.S. GAAP revenue recognition guidance. This new standard requires an entity to recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which an entity expects to be entitled in exchange for those goods or services. In addition, ASU 2014-09 contains expanded disclosure requirements relating to the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. ASU 2014-09 is effective for fiscal periods beginning after December 15, 2016 and permits the use of either the full retrospective or cumulative effect transition method. Early adoption is not permitted. We have not yet selected a transition method and are evaluating the impact that this new standard will have on our consolidated financial statements.

Cash_and_Cash_Equivalents

Cash and Cash Equivalents	3 Months Ended
	Mar. 31, 2015
Cash and Cash Equivalents [Abstract]
Cash and Cash Equivalents	Cash and Cash Equivalents
	Cash and cash equivalents were held in the following geographic regions:
	(In thousands)	March 31,		December 31,
		2015		2014
	United States	$	20,134	$	43,546
	Asia	63,540		50,799
	Europe	10,424		12,912
	South America	3,004		5,264
	Total cash and cash equivalents	$	97,102	$	112,521

Accounts_Receivable_Net_and_Re

Accounts Receivable, Net and Revenue Concentrations	3 Months Ended
	Mar. 31, 2015
Receivables [Abstract]
Accounts Receivable, Net and Revenue Concentrations	Accounts Receivable, Net and Revenue Concentrations
	Accounts receivable, net were as follows:
	(In thousands)	March 31,			December 31,
		2015			2014
	Trade receivables, gross	$	88,959		$	91,605
	Allowance for doubtful accounts	(600		)	(616		)
	Allowance for sales returns	(538		)	(617		)
	Net trade receivables	87,821			90,372
	Other	5,987			7,617
	Accounts receivable, net	$	93,808		$	97,989
	Allowance for Doubtful Accounts
	Changes in the allowance for doubtful accounts were as follows:
	(In thousands)	Three Months Ended March 31,
		2015			2014
	Balance at beginning of period	$	616		$	478
	Additions to costs and expenses	2			61
	(Write-offs)/FX effects	(18		)	6
	Balance at end of period	$	600		$	545
	Sales Returns
	The allowance for sales returns at March 31, 2015 and December 31, 2014 included reserves for items returned prior to period-end that were not completely processed, and therefore had not yet been removed from the allowance for sales returns balance. If these returns had been fully processed, the allowance for sales returns balance would have been approximately $0.3 million and $0.4 million on March 31, 2015 and December 31, 2014, respectively. The value of these returned goods was included in our inventory balance at March 31, 2015 and December 31, 2014.
	Significant Customers
	Net sales to the following customers totaled more than 10% of our net sales:
		Three Months Ended March 31,
		2015						2014
		$ (thousands)			% of Net Sales			$ (thousands)			% of Net Sales
	DIRECTV	$	17,365		13.1	%		$	14,716		11.3	%
	Comcast Corporation	15,577			11.7			—		(1)	—		(1)
	(1)	Net sales to this customer did not total more than 10% of our total net sales in the prior period.
	Trade receivables associated with Comcast Corporation accounted for $10.6 million, or 11.3%, of our accounts receivable, net at March 31, 2015. We had no other customers with trade receivables greater than 10% of our accounts receivable, net at March 31, 2015 or December 31, 2014.
	The loss of these customers or any other customer, either in the United States or abroad, due to their financial weakness or bankruptcy, or our inability to obtain orders or maintain our order volume with them, may have a material adverse effect on our financial condition, results of operations and cash flows.

Inventories_Net_and_Significan

Inventories, Net and Significant Suppliers	3 Months Ended
	Mar. 31, 2015
Inventory Disclosure [Abstract]
Inventories, Net and Significant Suppliers	Inventories, Net and Significant Suppliers
	Inventories, net were as follows:
	(In thousands)	March 31, 2015				December 31, 2014
	Raw materials	$	29,253			$	24,763
	Components	14,839				16,170
	Work in process	4,927				2,622
	Finished goods	53,699				56,458
	Reserve for excess and obsolete inventory	(2,537		)		(2,539		)
	Inventories, net	$	100,181			$	97,474
	Reserve for Excess and Obsolete Inventory
	Changes in the reserve for excess and obsolete inventory were as follows:
	(In thousands)	Three Months Ended March 31,
		2015				2014
	Balance at beginning of period	$	2,539			$	2,714
	Additions charged to costs and expenses (1)	811				551
	Sell through (2)	(406		)		(205		)
	Write-offs/FX effects	(407		)		(462		)
	Balance at end of period	$	2,537			$	2,598
	-1	The additions charged to costs and expenses do not include inventory directly written-off that was scrapped during production totaling $95 thousand and $45 thousand for the three months ended March 31, 2015 and 2014, respectively. These amounts are production waste and are not included in management's reserve for excess and obsolete inventory.
	-2	These amounts represent the reversal of reserves associated with inventory items that were sold during the period.
	Significant Suppliers
	We purchase integrated circuits, components and finished goods from multiple sources. We had purchases from the following significant suppliers that totaled more than 10% of our total inventory purchases as follows:
		Three Months Ended March 31,
		2015							2014
		$ (thousands)				% of Total			$ (thousands)			% of Total
						Inventory						Inventory
						Purchases						Purchases
	Victory Chemical Co., Ltd.	$	8,230			11.2	%		$	—	(1)	—	%	(1)
	Maxim Integrated Products International Limited	—			(1)	—		(1)	8,054			13
	(1)	Purchases from this supplier did not total more than 10% of our total inventory purchases in this period.
	Related Party Vendor
	We purchase certain printed circuit board assemblies from a related party vendor. The vendor is considered a related party for financial reporting purposes because our Senior Vice President of Manufacturing owns 40% of this vendor. Inventory purchases from this vendor were as follows:
		Three Months Ended March 31,
		2015							2014
		$ (thousands)				% of Total			$ (thousands)			% of Total
						Inventory Purchases						Inventory Purchases
	Related party vendor	$	2,094			2.9	%		$	1,723		2.8	%
	Total accounts payable to this vendor were as follows:
		March 31, 2015							December 31, 2014
		$ (thousands)				% of Accounts Payable			$ (thousands)			% of Accounts Payable
	Related party vendor	$	2,131			3.3	%		$	2,378		3.4	%
	Our payable terms and pricing with this vendor are consistent with the terms offered by other vendors in the ordinary course of business. The accounting policies that we apply to our transactions with our related party vendor are consistent with those applied in transactions with independent third parties. Corporate management routinely monitors purchases from our related party vendor to ensure these purchases remain consistent with our business objectives.

Goodwill_and_Intangible_Assets

Goodwill and Intangible Assets, Net	3 Months Ended
	Mar. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets, Net	Goodwill and Intangible Assets, Net
	Goodwill
	Goodwill and changes in the carrying amount of goodwill were as follows:
	(In thousands)
	Balance at December 31, 2014	$	30,739
	FX effects	(214		)
	Balance at March 31, 2015	$	30,525
	Intangible Assets, Net
	The components of intangible assets, net were as follows:
		March 31, 2015								December 31, 2014
	(In thousands)	Gross (1)			Accumulated			Net		Gross (1)		Accumulated			Net
					Amortization (1)							Amortization (1)
	Distribution rights	$	308		$	(74	)	$	234	$	347	$	(76	)	$	271
	Patents	10,471			(4,675		)	5,796		10,107		(4,736		)	5,371
	Trademark and trade names	2,001			(884		)	1,117		2,001		(834		)	1,167
	Developed and core technology	3,506			(1,432		)	2,074		3,506		(1,373		)	2,133
	Capitalized software development costs	276			(119		)	157		276		(85		)	191
	Customer relationships	26,406			(11,559		)	14,847		26,406		(10,925		)	15,481
	Total intangible assets, net	$	42,968		$	(18,743	)	$	24,225	$	42,643	$	(18,029	)	$	24,614
	(1)	This table excludes the gross value of fully amortized intangible assets totaling $8.2 million and $7.9 million on March 31, 2015 and December 31, 2014, respectively.
	Amortization expense is recorded in selling, general and administrative expenses, except amortization expense related to capitalized software development costs which is recorded in cost of sales. Amortization expense by income statement caption was as follows:
		Three Months Ended March 31,
	(In thousands)	2015			2014
	Cost of sales	$	35		$	37
	Selling, general and administrative	1,004			986
	Total amortization expense	$	1,039		$	1,023
	Estimated future amortization expense related to our intangible assets at March 31, 2015, is as follows:
	(In thousands)
	2015 (remaining 9 months)	$	3,094
	2016	4,077
	2017	3,992
	2018	3,973
	2019	3,973
	Thereafter	5,116
	Total	$	24,225

Line_of_Credit

Line of Credit	3 Months Ended
	Mar. 31, 2015
Debt Disclosure [Abstract]
Line of Credit	Line of Credit
	On October 9, 2014, we extended the term of our Amended and Restated Credit Agreement ("Amended Credit Agreement") with U.S. Bank National Association ("U.S. Bank") to November 1, 2017. The Amended Credit Agreement provides for a $55.0 million line of credit ("Credit Line") that may be used for working capital and other general corporate purposes including acquisitions, share repurchases and capital expenditures. Amounts available for borrowing under the Credit Line are reduced by the balance of any outstanding letters of credit, of which there were $13 thousand at March 31, 2015.
	All obligations under the Credit Line are secured by substantially all of our U.S. personal property and tangible and intangible assets as well as 65% of our ownership interest in Enson Assets Limited, our wholly-owned subsidiary which controls our manufacturing factories in the People's Republic of China ("PRC").
	Under the Amended Credit Agreement, we may elect to pay interest on the Credit Line based on LIBOR plus an applicable margin (varying from 1.25% to 1.75%) or base rate (based on the prime rate of U.S. Bank or as otherwise specified in the Amended Credit Agreement) plus an applicable margin (varying from 0.00% to 0.50%). The applicable margins are calculated quarterly and vary based on our cash flow leverage ratio as set forth in the Amended Credit Agreement. There are no commitment fees or unused line fees under the Amended Credit Agreement.
	The Amended Credit Agreement includes financial covenants requiring a minimum fixed charge coverage ratio and a maximum cash flow leverage ratio. In addition, the Amended Credit Agreement also contains other customary affirmative and negative covenants and events of default. As of March 31, 2015, we were in compliance with the covenants and conditions of the Amended Credit Agreement.

Income_Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2015
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes
	We utilize our estimated annual effective tax rate to determine our provision for income taxes for interim periods. The income tax provision is computed by taking the estimated annual effective tax rate and multiplying it by the year-to-date pre-tax book income.
	We recorded income tax expense of $1.3 million and $1.4 million for the three months ended March 31, 2015 and 2014, respectively. Our effective tax rate was 19.5% and 24.0% during the three months ended March 31, 2015 and 2014, respectively. The decrease in our effective tax rate was primarily due to the recording of a $0.3 million tax refund during the three months ended March 31, 2015 related to certain deductible research and development expenses incurred in China during 2013.
	At March 31, 2015, we had gross unrecognized tax benefits of $3.7 million, including interest and penalties, of which $3.2 million would affect the annual effective tax rate if these tax benefits are realized. Further, we are unaware of any positions for which it is reasonably possible that the total amount of unrecognized tax benefits will significantly increase within the next twelve months. However, based on federal, state and foreign statute expirations in various jurisdictions, we anticipate a decrease in unrecognized tax benefits of approximately $0.5 million within the next twelve months. We have classified uncertain tax positions as non-current income tax liabilities unless expected to be paid within one year.
	We have elected to classify interest and penalties as a component of tax expense. Accrued interest and penalties of $0.2 million and $0.2 million on March 31, 2015 and December 31, 2014, respectively, are included in our unrecognized tax benefits.
	We file income tax returns in the U.S. federal jurisdiction, and in various state and foreign jurisdictions. On March 31, 2015, the open statutes of limitations in our significant tax jurisdictions were as follows: federal 2011 through 2013, state 2010 through 2013, and foreign 2008 through 2013.

Accrued_Compensation

Accrued Compensation	3 Months Ended
	Mar. 31, 2015
Payables and Accruals [Abstract]
Accrued Compensation	Accrued Compensation
	The components of accrued compensation were as follows:
	(In thousands)	March 31, 2015		December 31, 2014
	Accrued social insurance (1)	$	19,898	$	19,941
	Accrued salary/wages	7,073		6,114
	Accrued vacation/holiday	2,596		2,222
	Accrued bonus (2)	1,787		8,492
	Accrued commission	386		1,797
	Accrued medical insurance claims	309		236
	Other accrued compensation	2,170		1,854
	Total accrued compensation	$	34,219	$	40,656
	(1)	Effective January 1, 2008, the Chinese Labor Contract Law was enacted in the PRC. This law mandated that PRC employers remit the applicable social insurance payments to their local government. Social insurance is comprised of various components such as pension, medical insurance, job injury insurance, unemployment insurance, and a housing assistance fund, and is administered in a manner similar to social security in the United States. This amount represents our estimate of the amounts due to the PRC government for social insurance on March 31, 2015 and December 31, 2014.
	(2)	Accrued bonus includes an accrual for an extra month of salary ("13th month salary") to be paid to employees in certain geographies where it is the customary business practice. This 13th month salary is paid to these employees if they remain employed with us through December 31st. The total accrued for the 13th month salary was $0.3 million and $0.6 million at March 31, 2015 and December 31, 2014, respectively.
	Other Accrued Expenses
	The components of other accrued expenses were as follows:
	(In thousands)	March 31, 2015		December 31, 2014
	Advertising and marketing	$	156	$	174
	Deferred revenue	766		648
	Duties	801		947
	Freight and handling fees	1,976		1,522
	Product development	518		751
	Product warranty claim costs	173		353
	Professional fees	1,713		1,493
	Sales taxes and VAT	1,666		2,057
	Third-party commissions	581		553
	Tooling (1)	648		1,089
	Unrealized loss on foreign currency exchange futures contracts	57		113
	Utilities	313		275
	Other	3,038		3,383
	Total other accrued expenses	$	12,406	$	13,358
	(1)	The tooling accrual balance relates to unearned revenue for tooling that will be sold to customers.

Other_Accrued_Expenses

Other Accrued Expenses	3 Months Ended
	Mar. 31, 2015
Payables and Accruals [Abstract]
Other Accrued Expenses	Accrued Compensation
	The components of accrued compensation were as follows:
	(In thousands)	March 31, 2015		December 31, 2014
	Accrued social insurance (1)	$	19,898	$	19,941
	Accrued salary/wages	7,073		6,114
	Accrued vacation/holiday	2,596		2,222
	Accrued bonus (2)	1,787		8,492
	Accrued commission	386		1,797
	Accrued medical insurance claims	309		236
	Other accrued compensation	2,170		1,854
	Total accrued compensation	$	34,219	$	40,656
	(1)	Effective January 1, 2008, the Chinese Labor Contract Law was enacted in the PRC. This law mandated that PRC employers remit the applicable social insurance payments to their local government. Social insurance is comprised of various components such as pension, medical insurance, job injury insurance, unemployment insurance, and a housing assistance fund, and is administered in a manner similar to social security in the United States. This amount represents our estimate of the amounts due to the PRC government for social insurance on March 31, 2015 and December 31, 2014.
	(2)	Accrued bonus includes an accrual for an extra month of salary ("13th month salary") to be paid to employees in certain geographies where it is the customary business practice. This 13th month salary is paid to these employees if they remain employed with us through December 31st. The total accrued for the 13th month salary was $0.3 million and $0.6 million at March 31, 2015 and December 31, 2014, respectively.
	Other Accrued Expenses
	The components of other accrued expenses were as follows:
	(In thousands)	March 31, 2015		December 31, 2014
	Advertising and marketing	$	156	$	174
	Deferred revenue	766		648
	Duties	801		947
	Freight and handling fees	1,976		1,522
	Product development	518		751
	Product warranty claim costs	173		353
	Professional fees	1,713		1,493
	Sales taxes and VAT	1,666		2,057
	Third-party commissions	581		553
	Tooling (1)	648		1,089
	Unrealized loss on foreign currency exchange futures contracts	57		113
	Utilities	313		275
	Other	3,038		3,383
	Total other accrued expenses	$	12,406	$	13,358
	(1)	The tooling accrual balance relates to unearned revenue for tooling that will be sold to customers.

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies
	Product Warranties
	Changes in the liability for product warranty claim costs were as follows:
	(In thousands)	Three Months Ended March 31,
		2015			2014
	Balance at beginning of period	$	353		$	41
	Accruals for warranties issued during the period	—			21
	Settlements (in cash or in kind) during the period	(180		)	(41		)
	Balance at end of period	$	173		$	21
	Litigation
	On March 2, 2012, we filed a lawsuit against Universal Remote Control, Inc. ("URC") in the United States District Court, Central District of California (Universal Electronics Inc. v. Universal Remote Control, Inc., SACV12-0039 AG (JPRx)) alleging that URC was infringing, directly and indirectly, four of our patents related to remote control technology. We alleged that this complaint related to multiple URC remote control products, including the URC model numbers UR5U-9000L, WR7 and other remote controls with different model names or numbers, but with substantially the same designs, features, and functionalities. We sought monetary relief for the infringement, including enhanced damages due to the willfulness of URC's actions, injunctive relief to enjoin URC from further infringing, including contributory infringement and/or inducing infringement, and attorney's fees. URC denied infringing our patents and asserted a variety of counterclaims and affirmative defenses including invalidity and unenforceability of our patents, misuse of patents, and a breach of contract action stemming from the settlement by us of an earlier lawsuit against URC. On January 29, 2013, the Court held its "Markman" hearing and on February 1, 2013, the Court issued its ruling that four of the 24 claims we asserted against URC were invalid, effectively removing one of the four patents alleged by us to be infringed by URC from this litigation. In March 2014, the Court further narrowed the scope of this litigation granting URC's motion for summary judgment with respect to certain issues that effectively removed two additional patents. In March 2014, the Court also granted our motion for summary judgment on certain of URC's defenses and counterclaims, including URC's counterclaim for breach of contract. A trial was held from May 6, 2014 through May 20, 2014, and the jury returned a verdict that URC did not infringe on our remaining patent, and found for URC on patent validity and several equitable defenses in the lawsuit, although the jury's verdict on the equitable defenses was advisory in nature. A hearing on motions pertaining to the jury's verdict was held on August 18, 2014. On December 16, 2014, the Court entered its findings of fact and conclusions of law on the equitable issues and determined that our assertion of URC's infringement of one of the patents at issue was barred by laches, but not by equitable estoppel or patent misuse. Further, the Court determined that our right to seek relief was not barred by unclean hands and on January 27, 2015, final judgment was entered by the Court accepting the jury's verdict pertaining to invalidity, non-infringement, marking, and the equitable defense of laches and ordered us to pay URC's costs of litigation, exclusive of attorney's fees. The parties have filed briefs in support of and opposition to the amount of such costs and fees to be awarded. URC is seeking an award of its costs in excess of $0.2 million. We have vigorously opposed this request as unreasonably excessive. We are awaiting the Court's determination of the amount of the award and depending upon the Court's decision, we will decide whether to appeal the ruling or not. At this time, since URC's and our opinions are very far apart as to the amount of costs to which URC should be awarded, we cannot estimate the amount the Court may award. On January 22, 2015, URC filed a motion seeking to recover its attorneys' fees and expenses incurred in connection with its defense of this lawsuit. We opposed this motion. On March 10, 2015, after a hearing, the Court granted URC's motion for a portion of its attorneys' fees and expenses and the parties have filed briefs in support of and opposition to the amount of fees and expenses to be awarded. URC is seeking an award of attorneys' fees and expenses in excess of $5.7 million. We have vigorously opposed this request as unreasonably excessive. We are awaiting the Court's determination of the amount of the award and depending upon the Court's decision, we will decide whether to appeal the ruling or not. At this time, since URC's and our opinions are very far apart as to the amount of fees and expenses to which URC could be awarded and due to the lack of guiding judicial precedent, we cannot estimate the amount the Court may award and thus no accrual for potential loss has been recorded as of March 31, 2015. On February 26, 2015, URC filed its notice of appeal with respect to rulings against it pertaining to the issues of patent misuse, unclean hands, implied license and all adverse orders, decisions, and opinions rulings of the Court, which appeal we will vigorously defend against and on March 11, 2015, we filed our notice of appeal with respect to the final judgment entered against us on January 27, 2015, with respect to the Court's claim construction order entered on February 1, 2013 and from the order granted URC's motion for attorneys' fees. Finally, on April 8, 2015, URC filed its notice of appeal with respect to the Court's order granting its motion for attorneys' fees.
	On June 28, 2013, we filed a second lawsuit against URC, also in the United States District Court, Central District of California (Universal Electronics Inc. v. Universal Remote Control, Inc., SACV13-00987 JAK (SHx)). In this second lawsuit, we are alleging that URC is infringing, directly and indirectly, ten additional patents that we own related to remote control technology. As in the first lawsuit, in this second lawsuit we have alleged that this complaint relates to multiple URC remote control products. We are seeking monetary relief for infringement, including enhanced damages due to the willfulness of URC's actions, injunctive relief to enjoin URC from further infringing, including contributory infringement and/or inducing infringement, and attorney's fees. In mid-July 2013, URC filed a Notice of Related Cases seeking to join this lawsuit with the lawsuit we filed against URC on March 2, 2012 and we did not object to this Notice. Consequently, this lawsuit was transferred to the Judge and Magistrate hearing our first lawsuit filed against URC. In addition, URC answered this complaint with a denial of infringement, asserting affirmative defenses, and seeking a ruling that URC has not infringed our patents, that our patents are invalid and unenforceable, that the patents have been licensed to URC, and an award of attorneys' fees and costs. In mid-November 2013, we filed a motion to add affiliated URC suppliers, Ohsung Electronics Co, Ltd, a South Korean entity, and Ohsung Electronics USA, Inc., a California entity, (collectively "Ohsung"), to the lawsuit. In February 2014, Ohsung answered and counterclaimed with a general denial of wrongdoing and asserted the standard affirmative defenses of non-infringement, invalidity and unenforceability of our patents and breach of contract action stemming from the settlement by us of an earlier lawsuit against URC. In March 2014, we answered by disputing Ohsung's defenses and with a general denial of Ohsung's breach of contract complaint. In late June and early July of 2014, URC and Ohsung requested inter partes review ("IPR") with the US Patent and Trademark Office ("Patent Office" or "USPTO") for each of the ten patents pending in the second URC lawsuit. We intend to vigorously defend each patent before the Patent Office. During December 2014 and January 2015, the Patent Office issued its decisions on URC's petitions and accepted for review all claims at issue with respect to five of the patents, certain claims at issue with respect to two of the patents and denied in full the request to review the other three patents at issue.We are presently reviewing the Patent Office's decisions to determine our next steps which could include appealing the Patent Office's acceptance of some or all of the seven patents and/or defending the patents in front of the USPTO. While the Patent Office was considering the IPR requests, this second lawsuit was stayed by the Court. On March 5, 2015, the Court granted the parties Joint Stipulation agreeing that the stay continue while the Patent Office decides the IPRs, which decisions are not expected until January 2016.
	There are no other material pending legal proceedings to which we or any of our subsidiaries is a party or of which our respective property is the subject. However, as is typical in our industry and to the nature and kind of business in which we are engaged, from time to time, various claims, charges and litigation are asserted or commenced by third parties against us or by us against third parties arising from or related to product liability, infringement of patent or other intellectual property rights, breach of warranty, contractual relations, or employee relations. The amounts claimed may be substantial but may not bear any reasonable relationship to the merits of the claims or the extent of any real risk of court awards assessed against us or in our favor. However, no assurances can be made as to the outcome of any of these matters, nor can we estimate the range of potential losses to us. In our opinion, final judgments, if any, which might be rendered against us in potential or pending litigation would not have a material adverse effect on our financial condition, results of operations, or cash flows. Moreover, we believe that our products do not infringe any third parties' patents or other intellectual property rights.
	We maintain directors' and officers' liability insurance which insures our individual directors and officers against certain claims, as well as attorney's fees and related expenses incurred in connection with the defense of such claims.

Treasury_Stock

Treasury Stock	3 Months Ended
	Mar. 31, 2015
Equity [Abstract]
Treasury Stock	Treasury Stock
	Repurchased shares of our common stock were as follows:
		Three Months Ended March 31,
	(In thousands, except share data)	2015		2014
	Shares repurchased	69,460		11,112
	Cost of shares repurchased	$	4,021	$	405
	Repurchased shares are recorded as shares held in treasury at cost. We hold these shares for future use as management and the Board of Directors deem appropriate, which has included compensating our outside directors. During the three months ended March 31, 2014, we issued 7,500 shares from treasury to outside directors for services performed (see Note 13).
	From time to time, our Board of Directors authorizes management to repurchase shares of our issued and outstanding common stock. Repurchases may be made to manage dilution created by shares issued under our stock incentive plans or whenever we deem a repurchase is a good use of our cash and the price to be paid is at or below a threshold approved by our Board. As of March 31, 2015, we had 998,195 shares available for repurchase under the Board's authorizations. On April 29, 2015, our Board increased these repurchase authorizations by 101,805 shares bringing the total authorization as of the approval date to 1,100,000 shares.

Business_Segment_and_Foreign_O

Business Segment and Foreign Operations	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Business Segment and Foreign Operations	Business Segment and Foreign Operations
	Reportable Segment
	An operating segment, in part, is a component of an enterprise whose operating results are regularly reviewed by the chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance. Operating segments may be aggregated only to a limited extent. Our chief operating decision maker, the Chief Executive Officer, reviews financial information presented on a consolidated basis, accompanied by disaggregated information about revenues for purposes of making operating decisions and assessing financial performance. Accordingly, we only have a single operating and reportable segment.
	Foreign Operations
	Our net sales to external customers by geographic area were as follows:
		Three Months Ended March 31,
	(In thousands)	2015		2014
	United States	$	54,759	$	47,896
	Asia (excluding PRC)	31,020		31,518
	People's Republic of China	15,836		20,670
	Europe	15,022		15,271
	Latin America	10,522		9,025
	Other	5,546		5,465
	Total net sales	$	132,705	$	129,845
	Specific identification of the customer billing location was the basis used for attributing revenues from external customers to geographic areas.
	Long-lived tangible assets by geographic area were as follows:
	(In thousands)	March 31, 2015		December 31, 2014
	United States	$	5,631	$	5,716
	People's Republic of China	74,563		70,619
	All other countries	4,637		5,271
	Total long-lived tangible assets	$	84,831	$	81,606

StockBased_Compensation

Stock-Based Compensation	3 Months Ended
	Mar. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock-Based Compensation	Stock-Based Compensation
	Stock-based compensation expense for each employee and director is presented in the same income statement caption as their cash compensation. Stock-based compensation expense by income statement caption and the related income tax benefit were as follows:
		Three Months Ended March 31,
	(In thousands)	2015				2014
	Cost of sales	$	9			$	4
	Research and development	105				101
	Selling, general and administrative:
	Employees	1,471				1,358
	Outside directors	374				215
	Total stock-based compensation expense	$	1,959			$	1,678
	Income tax benefit	$	560			$	490
	Stock Options
	Stock option activity was as follows:
		Number of Options			Weighted-Average Exercise Price				Weighted-Average Remaining Contractual Terms	Aggregate Intrinsic Value
		(in 000's)							(in years)	(in 000's)
	Outstanding at December 31, 2014	650			$	25.56
	Granted	74			65.54
	Exercised	(39	)		25.6					$	1,205
	Forfeited/canceled/expired	(7	)		21.54
	Outstanding on March 31, 2015 (1)	678			$	29.94			4.94	$	18,647
	Vested and expected to vest on March 31, 2015 (1)	678			$	29.95			4.94	$	18,633
	Exercisable on March 31, 2015 (1)	449			$	24.58			4.99	$	14,318
	(1)	The aggregate intrinsic value represents the total pre-tax value (the difference between our closing stock price on the last trading day of the first quarter of 2015 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had they all exercised their options on March 31, 2015. This amount will change based on the fair market value of our stock.
	The assumptions we utilized in the Black-Scholes option pricing model and the resulting weighted average fair value of stock option grants were the following:
		Three Months Ended March 31,
		2015				2014
	Weighted average fair value of grants (1)	$	24.77			$	13.64
	Risk-free interest rate	1.38		%		1.29		%
	Expected volatility	43.5		%		44.84		%
	Expected life in years	4.56				4.56
	(1)	The weighted average fair value of grants was calculated utilizing the stock options granted during each respective period.
	As of March 31, 2015, we expect to recognize $3.4 million of total unrecognized pre-tax stock-based compensation expense related to non-vested stock options over a remaining weighted-average life of 2.2 years.
	Restricted Stock
	Non-vested restricted stock award activity was as follows:
		Shares Granted			Weighted-Average Grant Date Fair Value
		(in 000's)
	Non-vested at December 31, 2014	266			$	39.28
	Granted	29			65.53
	Vested	(38	)		33.04
	Forfeited	—			—
	Non-vested at March 31, 2015	257			$	43.13
	As of March 31, 2015, we expect to recognize $9.9 million of total unrecognized pre-tax stock-based compensation expense related to non-vested restricted stock awards over a weighted-average life of 2.3 years.

Other_Income_Expense_Net

Other Income (Expense), Net	3 Months Ended
	Mar. 31, 2015
Other Income and Expenses [Abstract]
Other Income (Expense), Net	Other Income (Expense), Net
	Other income (expense), net consisted of the following:
		Three Months Ended March 31,
	(In thousands)	2015			2014
	Net gain (loss) on foreign currency exchange contracts (1)	$	1,034		$	(1,049	)
	Net gain (loss) on foreign currency exchange transactions	(854		)	693
	Other income (expense)	50			7
	Other income (expense), net	$	230		$	(349	)
	(1)	This represents the gains and (losses) incurred on foreign currency hedging derivatives (see Note 16 for further details).

Earnings_Per_Share

Earnings Per Share	3 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share
	Earnings per share was calculated as follows:
		Three Months Ended March 31,
	(In thousands, except per-share amounts)	2015			2014
	BASIC
	Net income	$	5,189		$	4,273
	Weighted-average common shares outstanding	15,907			15,787
	Basic earnings per share	$	0.33		$	0.27
	DILUTED
	Net income	$	5,189		$	4,273
	Weighted-average common shares outstanding for basic	15,907			15,787
	Dilutive effect of stock options and restricted stock	336			376
	Weighted-average common shares outstanding on a diluted basis	16,243			16,163
	Diluted earnings per share	$	0.32		$	0.26
	The number of stock options and shares of restricted stock excluded from the computation of diluted earnings per common share were as follows:
		Three Months Ended March 31,
	(In thousands)	2015		2014
	Stock options	40		73
	Restricted stock awards	16		28

Derivatives

Derivatives	3 Months Ended
	Mar. 31, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives	Derivatives
	We periodically enter into foreign currency exchange contracts with terms normally lasting less than nine months to protect against the adverse effects that exchange-rate fluctuations may have on our foreign currency-denominated receivables, payables, cash flows and reported income. We are exposed to market risks from foreign currency exchange rates, which may adversely affect our operating results and financial position. Our foreign currency exposures are primarily concentrated in the Argentinian Peso, Brazilian Real, British Pound, Chinese Yuan Renminbi, Euro, Hong Kong Dollar, and Indian Rupee. Derivative financial instruments are used to manage risk and are not used for trading or other speculative purposes. We do not use leveraged derivative financial instruments and these derivatives have not qualified for hedge accounting.
	Gains and losses on the derivatives are recorded in other income (expense), net. Derivatives are recorded on the balance sheet at fair value. The estimated fair values of our derivative financial instruments represent the amount required to enter into offsetting contracts with similar remaining maturities based on quoted market prices. We have determined that the fair value of our derivatives are derived from level 2 inputs in the fair value hierarchy. The following table sets forth the total net fair value of derivatives:
			31-Mar-15											31-Dec-14
			Fair Value Measurement Using								Total			Fair Value Measurement Using						Total
	(In thousands)		(Level 1)			(Level 2)		(Level 3)			Balance			(Level 1)		(Level 2)		(Level 3)		Balance
	Foreign currency exchange futures contracts		$	—		$	460	$	—		$	460		$	—	$	810	$	—	$	810
	We held foreign currency exchange contracts which resulted in a net pre-tax gain of $1.0 million for the three months ended March 31, 2015 and a net pre-tax loss of $1.0 million for the three months ended March 31, 2014, respectively.
	Details of futures contracts held were as follows:
	Date Held		Type		Position Held	Notional Value		Forward Rate		Gain/(Loss) Recorded at Balance Sheet			Settlement Date
						(in millions)				Date
										(in thousands)(1)
	March 31, 2015		USD/Euro		USD	$	5	1.0989		$	110		April 24, 2015
	March 31, 2015		USD/Chinese Yuan		Chinese Yuan	$	22.5	6.2645		$	(57	)	July 17, 2015
			Renminbi		Renminbi
	March 31, 2015		USD/Brazilian Real		USD	$	2.5	2.769		$	407		July 17, 2015
	December 31, 2014		USD/Euro		USD	$	5	1.245		$	140		January 23, 2015
	December 31, 2014		USD/Chinese Yuan		Chinese Yuan	$	20	6.2757		$	174		January 16, 2015
			Renminbi		Renminbi
	December 31, 2014		USD/Brazilian Real		USD	$	5	2.3401		$	609		January 16, 2015
	December 31, 2014		USD/Brazilian Real		Brazilian Real	$	2.5	2.5442		$	(113	)	January 16, 2015
	(1)	Gains on futures contracts are recorded in prepaid expenses and other current assets. Losses on futures contracts are recorded in other accrued expenses.

Basis_of_Presentation_and_Sign1

Basis of Presentation and Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Consolidation	In the opinion of management, the accompanying consolidated financial statements of Universal Electronics Inc. and its wholly-owned subsidiaries contain all the adjustments necessary for a fair presentation of financial position, results of operations and cash flows for the periods presented. All such adjustments are of a normal recurring nature and certain reclassifications have been made to prior year amounts in order to conform to the current year presentation. Information and footnote disclosures normally included in financial statements, which are prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"), have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission. As used herein, the terms "Company," "we," "us," and "our" refer to Universal Electronics Inc. and its subsidiaries, unless the context indicates to the contrary.
	Our results of operations for the three months ended March 31, 2015 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations," "Quantitative and Qualitative Disclosures About Market Risk," and the "Financial Statements and Supplementary Data" and notes thereto included in Items 1A, 7, 7A, and 8, respectively, of our Annual Report on Form 10-K for the year ended December 31, 2014.
Estimates, Judgments and Assumptions	Estimates, Judgments and Assumptions
	The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an on-going basis, we evaluate our estimates and assumptions, including those related to revenue recognition, allowances for sales returns and doubtful accounts, inventory valuation, our review of impairment of long-lived assets, intangible assets and goodwill, income taxes and stock-based compensation expense. Actual results may differ from these estimates and assumptions, and they may be adjusted as more information becomes available. Any adjustment may be material.
Recent Accounting Pronouncements	Recent Accounting Pronouncements
	In May 2014, the FASB issued ASU 2014-09, "Revenue from Contracts with Customers", which will supersede most existing U.S. GAAP revenue recognition guidance. This new standard requires an entity to recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which an entity expects to be entitled in exchange for those goods or services. In addition, ASU 2014-09 contains expanded disclosure requirements relating to the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. ASU 2014-09 is effective for fiscal periods beginning after December 15, 2016 and permits the use of either the full retrospective or cumulative effect transition method. Early adoption is not permitted. We have not yet selected a transition method and are evaluating the impact that this new standard will have on our consolidated financial statements.

Cash_and_Cash_Equivalents_Tabl

Cash and Cash Equivalents (Tables)	3 Months Ended
	Mar. 31, 2015
Cash and Cash Equivalents [Abstract]
Schedule of Cash and Cash Equivalents	Cash and cash equivalents were held in the following geographic regions:
	(In thousands)	March 31,		December 31,
		2015		2014
	United States	$	20,134	$	43,546
	Asia	63,540		50,799
	Europe	10,424		12,912
	South America	3,004		5,264
	Total cash and cash equivalents	$	97,102	$	112,521

Accounts_Receivable_Net_and_Re1

Accounts Receivable, Net and Revenue Concentrations (Tables)	3 Months Ended
	Mar. 31, 2015
Receivables [Abstract]
Schedule of Accounts Receivable	Accounts receivable, net were as follows:
	(In thousands)	March 31,			December 31,
		2015			2014
	Trade receivables, gross	$	88,959		$	91,605
	Allowance for doubtful accounts	(600		)	(616		)
	Allowance for sales returns	(538		)	(617		)
	Net trade receivables	87,821			90,372
	Other	5,987			7,617
	Accounts receivable, net	$	93,808		$	97,989
	Allowance for Doubtful Accounts
	Changes in the allowance for doubtful accounts were as follows:
	(In thousands)	Three Months Ended March 31,
		2015			2014
	Balance at beginning of period	$	616		$	478
	Additions to costs and expenses	2			61
	(Write-offs)/FX effects	(18		)	6
	Balance at end of period	$	600		$	545
Schedule of Significant Customers to Net Sales	Net sales to the following customers totaled more than 10% of our net sales:
		Three Months Ended March 31,
		2015						2014
		$ (thousands)			% of Net Sales			$ (thousands)			% of Net Sales
	DIRECTV	$	17,365		13.1	%		$	14,716		11.3	%
	Comcast Corporation	15,577			11.7			—		(1)	—		(1)
	(1)	Net sales to this customer did not total more than 10% of our total net sales in the prior period.

Inventories_Net_and_Significan1

Inventories, Net and Significant Suppliers (Tables)	3 Months Ended
	Mar. 31, 2015
Inventory Disclosure [Abstract]
Schedule of Inventories, Net	Inventories, net were as follows:
	(In thousands)	March 31, 2015				December 31, 2014
	Raw materials	$	29,253			$	24,763
	Components	14,839				16,170
	Work in process	4,927				2,622
	Finished goods	53,699				56,458
	Reserve for excess and obsolete inventory	(2,537		)		(2,539		)
	Inventories, net	$	100,181			$	97,474
Schedule of Reserve for Excess and Obsolete Inventory	Changes in the reserve for excess and obsolete inventory were as follows:
	(In thousands)	Three Months Ended March 31,
		2015				2014
	Balance at beginning of period	$	2,539			$	2,714
	Additions charged to costs and expenses (1)	811				551
	Sell through (2)	(406		)		(205		)
	Write-offs/FX effects	(407		)		(462		)
	Balance at end of period	$	2,537			$	2,598
	-1	The additions charged to costs and expenses do not include inventory directly written-off that was scrapped during production totaling $95 thousand and $45 thousand for the three months ended March 31, 2015 and 2014, respectively. These amounts are production waste and are not included in management's reserve for excess and obsolete inventory.
	-2	These amounts represent the reversal of reserves associated with inventory items that were sold during the period.
Schedule of Purchases from Significant Supplier(s) to Inventory	We had purchases from the following significant suppliers that totaled more than 10% of our total inventory purchases as follows:
		Three Months Ended March 31,
		2015							2014
		$ (thousands)				% of Total			$ (thousands)			% of Total
						Inventory						Inventory
						Purchases						Purchases
	Victory Chemical Co., Ltd.	$	8,230			11.2	%		$	—	(1)	—	%	(1)
	Maxim Integrated Products International Limited	—			(1)	—		(1)	8,054			13
	(1)	Purchases from this supplier did not total more than 10% of our total inventory purchases in this period.
Schedule of Related Party Transactions	We purchase certain printed circuit board assemblies from a related party vendor. The vendor is considered a related party for financial reporting purposes because our Senior Vice President of Manufacturing owns 40% of this vendor. Inventory purchases from this vendor were as follows:
		Three Months Ended March 31,
		2015							2014
		$ (thousands)				% of Total			$ (thousands)			% of Total
						Inventory Purchases						Inventory Purchases
	Related party vendor	$	2,094			2.9	%		$	1,723		2.8	%
	Total accounts payable to this vendor were as follows:
		March 31, 2015							December 31, 2014
		$ (thousands)				% of Accounts Payable			$ (thousands)			% of Accounts Payable
	Related party vendor	$	2,131			3.3	%		$	2,378		3.4	%

Goodwill_and_Intangible_Assets1

Goodwill and Intangible Assets, Net (Tables)	3 Months Ended
	Mar. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Goodwill and changes in the carrying amount of goodwill were as follows:
	(In thousands)
	Balance at December 31, 2014	$	30,739
	FX effects	(214		)
	Balance at March 31, 2015	$	30,525
Schedule of Components of Intangible Assets	The components of intangible assets, net were as follows:
		March 31, 2015								December 31, 2014
	(In thousands)	Gross (1)			Accumulated			Net		Gross (1)		Accumulated			Net
					Amortization (1)							Amortization (1)
	Distribution rights	$	308		$	(74	)	$	234	$	347	$	(76	)	$	271
	Patents	10,471			(4,675		)	5,796		10,107		(4,736		)	5,371
	Trademark and trade names	2,001			(884		)	1,117		2,001		(834		)	1,167
	Developed and core technology	3,506			(1,432		)	2,074		3,506		(1,373		)	2,133
	Capitalized software development costs	276			(119		)	157		276		(85		)	191
	Customer relationships	26,406			(11,559		)	14,847		26,406		(10,925		)	15,481
	Total intangible assets, net	$	42,968		$	(18,743	)	$	24,225	$	42,643	$	(18,029	)	$	24,614
	(1)	This table excludes the gross value of fully amortized intangible assets totaling $8.2 million and $7.9 million on March 31, 2015 and December 31, 2014, respectively.
Intangible Assets Amortization Expense	Amortization expense by income statement caption was as follows:
		Three Months Ended March 31,
	(In thousands)	2015			2014
	Cost of sales	$	35		$	37
	Selling, general and administrative	1,004			986
	Total amortization expense	$	1,039		$	1,023
Schedule of Estimated Future Amortization Expense	Estimated future amortization expense related to our intangible assets at March 31, 2015, is as follows:
	(In thousands)
	2015 (remaining 9 months)	$	3,094
	2016	4,077
	2017	3,992
	2018	3,973
	2019	3,973
	Thereafter	5,116
	Total	$	24,225

Accrued_Compensation_Tables

Accrued Compensation (Tables)	3 Months Ended
	Mar. 31, 2015
Payables and Accruals [Abstract]
Components of Accrued Compensation	The components of accrued compensation were as follows:
	(In thousands)	March 31, 2015		December 31, 2014
	Accrued social insurance (1)	$	19,898	$	19,941
	Accrued salary/wages	7,073		6,114
	Accrued vacation/holiday	2,596		2,222
	Accrued bonus (2)	1,787		8,492
	Accrued commission	386		1,797
	Accrued medical insurance claims	309		236
	Other accrued compensation	2,170		1,854
	Total accrued compensation	$	34,219	$	40,656
	(1)	Effective January 1, 2008, the Chinese Labor Contract Law was enacted in the PRC. This law mandated that PRC employers remit the applicable social insurance payments to their local government. Social insurance is comprised of various components such as pension, medical insurance, job injury insurance, unemployment insurance, and a housing assistance fund, and is administered in a manner similar to social security in the United States. This amount represents our estimate of the amounts due to the PRC government for social insurance on March 31, 2015 and December 31, 2014.
	(2)	Accrued bonus includes an accrual for an extra month of salary ("13th month salary") to be paid to employees in certain geographies where it is the customary business practice. This 13th month salary is paid to these employees if they remain employed with us through December 31st. The total accrued for the 13th month salary was $0.3 million and $0.6 million at March 31, 2015 and December 31, 2014, respectively.
	The components of other accrued expenses were as follows:
	(In thousands)	March 31, 2015		December 31, 2014
	Advertising and marketing	$	156	$	174
	Deferred revenue	766		648
	Duties	801		947
	Freight and handling fees	1,976		1,522
	Product development	518		751
	Product warranty claim costs	173		353
	Professional fees	1,713		1,493
	Sales taxes and VAT	1,666		2,057
	Third-party commissions	581		553
	Tooling (1)	648		1,089
	Unrealized loss on foreign currency exchange futures contracts	57		113
	Utilities	313		275
	Other	3,038		3,383
	Total other accrued expenses	$	12,406	$	13,358
	(1)	The tooling accrual balance relates to unearned revenue for tooling that will be sold to customers.

Other_Accrued_Expenses_Tables

Other Accrued Expenses (Tables)	3 Months Ended
	Mar. 31, 2015
Payables and Accruals [Abstract]
Components of Other Accrued Expenses	The components of accrued compensation were as follows:
	(In thousands)	March 31, 2015		December 31, 2014
	Accrued social insurance (1)	$	19,898	$	19,941
	Accrued salary/wages	7,073		6,114
	Accrued vacation/holiday	2,596		2,222
	Accrued bonus (2)	1,787		8,492
	Accrued commission	386		1,797
	Accrued medical insurance claims	309		236
	Other accrued compensation	2,170		1,854
	Total accrued compensation	$	34,219	$	40,656
	(1)	Effective January 1, 2008, the Chinese Labor Contract Law was enacted in the PRC. This law mandated that PRC employers remit the applicable social insurance payments to their local government. Social insurance is comprised of various components such as pension, medical insurance, job injury insurance, unemployment insurance, and a housing assistance fund, and is administered in a manner similar to social security in the United States. This amount represents our estimate of the amounts due to the PRC government for social insurance on March 31, 2015 and December 31, 2014.
	(2)	Accrued bonus includes an accrual for an extra month of salary ("13th month salary") to be paid to employees in certain geographies where it is the customary business practice. This 13th month salary is paid to these employees if they remain employed with us through December 31st. The total accrued for the 13th month salary was $0.3 million and $0.6 million at March 31, 2015 and December 31, 2014, respectively.
	The components of other accrued expenses were as follows:
	(In thousands)	March 31, 2015		December 31, 2014
	Advertising and marketing	$	156	$	174
	Deferred revenue	766		648
	Duties	801		947
	Freight and handling fees	1,976		1,522
	Product development	518		751
	Product warranty claim costs	173		353
	Professional fees	1,713		1,493
	Sales taxes and VAT	1,666		2,057
	Third-party commissions	581		553
	Tooling (1)	648		1,089
	Unrealized loss on foreign currency exchange futures contracts	57		113
	Utilities	313		275
	Other	3,038		3,383
	Total other accrued expenses	$	12,406	$	13,358
	(1)	The tooling accrual balance relates to unearned revenue for tooling that will be sold to customers.

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Schedule of Changes in Reserve for Product Warranty Claim Costs	Changes in the liability for product warranty claim costs were as follows:
	(In thousands)	Three Months Ended March 31,
		2015			2014
	Balance at beginning of period	$	353		$	41
	Accruals for warranties issued during the period	—			21
	Settlements (in cash or in kind) during the period	(180		)	(41		)
	Balance at end of period	$	173		$	21

Treasury_Stock_Tables

Treasury Stock (Tables)	3 Months Ended
	Mar. 31, 2015
Equity [Abstract]
Treasury Stock	Repurchased shares of our common stock were as follows:
		Three Months Ended March 31,
	(In thousands, except share data)	2015		2014
	Shares repurchased	69,460		11,112
	Cost of shares repurchased	$	4,021	$	405

Business_Segment_and_Foreign_O1

Business Segment and Foreign Operations (Tables)	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Schedule of Net Sales to External Customers by Geographic Area	Our net sales to external customers by geographic area were as follows:
		Three Months Ended March 31,
	(In thousands)	2015		2014
	United States	$	54,759	$	47,896
	Asia (excluding PRC)	31,020		31,518
	People's Republic of China	15,836		20,670
	Europe	15,022		15,271
	Latin America	10,522		9,025
	Other	5,546		5,465
	Total net sales	$	132,705	$	129,845
Schedule of Long-lived Assets	Long-lived tangible assets by geographic area were as follows:
	(In thousands)	March 31, 2015		December 31, 2014
	United States	$	5,631	$	5,716
	People's Republic of China	74,563		70,619
	All other countries	4,637		5,271
	Total long-lived tangible assets	$	84,831	$	81,606

StockBased_Compensation_Tables

Stock-Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Stock-based Compensation Expense	Stock-based compensation expense by income statement caption and the related income tax benefit were as follows:
		Three Months Ended March 31,
	(In thousands)	2015				2014
	Cost of sales	$	9			$	4
	Research and development	105				101
	Selling, general and administrative:
	Employees	1,471				1,358
	Outside directors	374				215
	Total stock-based compensation expense	$	1,959			$	1,678
	Income tax benefit	$	560			$	490
Schedule of Stock Option Activity	Stock option activity was as follows:
		Number of Options			Weighted-Average Exercise Price				Weighted-Average Remaining Contractual Terms	Aggregate Intrinsic Value
		(in 000's)							(in years)	(in 000's)
	Outstanding at December 31, 2014	650			$	25.56
	Granted	74			65.54
	Exercised	(39	)		25.6					$	1,205
	Forfeited/canceled/expired	(7	)		21.54
	Outstanding on March 31, 2015 (1)	678			$	29.94			4.94	$	18,647
	Vested and expected to vest on March 31, 2015 (1)	678			$	29.95			4.94	$	18,633
	Exercisable on March 31, 2015 (1)	449			$	24.58			4.99	$	14,318
	(1)	The aggregate intrinsic value represents the total pre-tax value (the difference between our closing stock price on the last trading day of the first quarter of 2015 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had they all exercised their options on March 31, 2015. This amount will change based on the fair market value of our stock.
Schedule of Black Scholes Assumptions	The assumptions we utilized in the Black-Scholes option pricing model and the resulting weighted average fair value of stock option grants were the following:
		Three Months Ended March 31,
		2015				2014
	Weighted average fair value of grants (1)	$	24.77			$	13.64
	Risk-free interest rate	1.38		%		1.29		%
	Expected volatility	43.5		%		44.84		%
	Expected life in years	4.56				4.56
	(1)	The weighted average fair value of grants was calculated utilizing the stock options granted during each respective period.
Schedule of Non-vested Restricted Stock Awards Activity	Non-vested restricted stock award activity was as follows:
		Shares Granted			Weighted-Average Grant Date Fair Value
		(in 000's)
	Non-vested at December 31, 2014	266			$	39.28
	Granted	29			65.53
	Vested	(38	)		33.04
	Forfeited	—			—
	Non-vested at March 31, 2015	257			$	43.13

Other_Income_Expense_Net_Table

Other Income (Expense), Net (Tables)	3 Months Ended
	Mar. 31, 2015
Other Income and Expenses [Abstract]
Schedule of Components of Other Income (Expense), Net	Other income (expense), net consisted of the following:
		Three Months Ended March 31,
	(In thousands)	2015			2014
	Net gain (loss) on foreign currency exchange contracts (1)	$	1,034		$	(1,049	)
	Net gain (loss) on foreign currency exchange transactions	(854		)	693
	Other income (expense)	50			7
	Other income (expense), net	$	230		$	(349	)
	(1)	This represents the gains and (losses) incurred on foreign currency hedging derivatives (see Note 16 for further details).

Earnings_Per_Share_Tables

Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Earnings Per Share	Earnings per share was calculated as follows:
		Three Months Ended March 31,
	(In thousands, except per-share amounts)	2015			2014
	BASIC
	Net income	$	5,189		$	4,273
	Weighted-average common shares outstanding	15,907			15,787
	Basic earnings per share	$	0.33		$	0.27
	DILUTED
	Net income	$	5,189		$	4,273
	Weighted-average common shares outstanding for basic	15,907			15,787
	Dilutive effect of stock options and restricted stock	336			376
	Weighted-average common shares outstanding on a diluted basis	16,243			16,163
	Diluted earnings per share	$	0.32		$	0.26
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The number of stock options and shares of restricted stock excluded from the computation of diluted earnings per common share were as follows:
		Three Months Ended March 31,
	(In thousands)	2015		2014
	Stock options	40		73
	Restricted stock awards	16		28

Derivatives_Tables

Derivatives (Tables)	3 Months Ended
	Mar. 31, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivatives at Fair Value on a Recurring Basis	The following table sets forth the total net fair value of derivatives:
			31-Mar-15											31-Dec-14
			Fair Value Measurement Using								Total			Fair Value Measurement Using						Total
	(In thousands)		(Level 1)			(Level 2)		(Level 3)			Balance			(Level 1)		(Level 2)		(Level 3)		Balance
	Foreign currency exchange futures contracts		$	—		$	460	$	—		$	460		$	—	$	810	$	—	$	810
Schedule of Futures Contracts	Details of futures contracts held were as follows:
	Date Held		Type		Position Held	Notional Value		Forward Rate		Gain/(Loss) Recorded at Balance Sheet			Settlement Date
						(in millions)				Date
										(in thousands)(1)
	March 31, 2015		USD/Euro		USD	$	5	1.0989		$	110		April 24, 2015
	March 31, 2015		USD/Chinese Yuan		Chinese Yuan	$	22.5	6.2645		$	(57	)	July 17, 2015
			Renminbi		Renminbi
	March 31, 2015		USD/Brazilian Real		USD	$	2.5	2.769		$	407		July 17, 2015
	December 31, 2014		USD/Euro		USD	$	5	1.245		$	140		January 23, 2015
	December 31, 2014		USD/Chinese Yuan		Chinese Yuan	$	20	6.2757		$	174		January 16, 2015
			Renminbi		Renminbi
	December 31, 2014		USD/Brazilian Real		USD	$	5	2.3401		$	609		January 16, 2015
	December 31, 2014		USD/Brazilian Real		Brazilian Real	$	2.5	2.5442		$	(113	)	January 16, 2015
	(1)	Gains on futures contracts are recorded in prepaid expenses and other current assets. Losses on futures contracts are recorded in other accrued expenses.

Cash_and_Cash_Equivalents_Geog

Cash and Cash Equivalents - Geographic Information (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	$97,102	$112,521	$90,400	$76,174
United States [Member]
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	20,134	43,546
Asia [Member]
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	63,540	50,799
Europe [Member]
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	10,424	12,912
South America [Member]
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	$3,004	$5,264

Accounts_Receivable_Net_and_Re2

Accounts Receivable, Net and Revenue Concentrations (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Accounts Receivable, Net, Current [Abstract]
Trade receivables, gross	$88,959	$91,605
Allowance for doubtful accounts	-600	-616	-545	-478
Allowance for sales returns	-538	-617
Net trade receivables	87,821	90,372
Other	5,987	7,617
Accounts receivable, net	$93,808	$97,989

Accounts_Receivable_Net_and_Re3

Accounts Receivable, Net and Revenue Concentrations - Allowance for Doubtful Accounts (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Schedule of Allowance for Doubtful Accounts
Balance at beginning of period	$616	$478
Additions to costs and expenses	2	61
(Write-offs)/FX effects	-18	6
Balance at end of period	$600	$545

Accounts_Receivable_Net_and_Re4

Accounts Receivable, Net and Revenue Concentrations - Sales Returns (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Millions, unless otherwise specified
Receivables [Abstract]
Allowance for sales return	$0.30	$0.40

Accounts_Receivable_Net_and_Re5

Accounts Receivable, Net and Revenue Concentrations - Significant Customers (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014		Dec. 31, 2014
Revenue and Accounts Receivable, Major Customer [Line Items]
Net sales	$132,705	$129,845
Accounts receivable, net	93,808			97,989
Sales [Member] | DIRECTV [Member]
Revenue and Accounts Receivable, Major Customer [Line Items]
Net sales	17,365	14,716
Concentration risk	13.10%	11.30%
Sales [Member] | Comcast Corporation [Member]
Revenue and Accounts Receivable, Major Customer [Line Items]
Net sales	15,577	0	[1]
Concentration risk	11.70%	0.00%	[1]
Trade Accounts Receivable [Member] | Comcast Corporation [Member]
Revenue and Accounts Receivable, Major Customer [Line Items]
Concentration risk	11.30%
Accounts receivable, net	$10,600
[1]	Net sales to this customer did not total more than 10% of our total net sales in the prior period.

Inventories_Net_and_Significan2

Inventories, Net and Significant Suppliers (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Inventory Disclosure [Abstract]
Raw materials	$29,253	$24,763
Components	14,839	16,170
Work in process	4,927	2,622
Finished goods	53,699	56,458
Reserve for excess and obsolete inventory	-2,537	-2,539	-2,598	-2,714
Inventories, net	$100,181	$97,474

Inventories_Net_and_Significan3

Inventories, Net and Significant Suppliers - Inventory Reserves (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015		Mar. 31, 2014
Schedule of Reserve for Excess and Obsolete Inventory
Balance at Beginning of Period	$2,539		$2,714
Additions Charged to Costs and Expenses	811	[1]	551	[1]
Sell Through	-406	[2]	-205	[2]
Write-offs/FX Effects	-407		-462
Balance at End of Period	2,537		2,598
Inventory Scrapped During Production	$95		$45
[1]	The additions charged to costs and expenses do not include inventory directly written-off that was scrapped during production totaling $95 thousand and $45 thousand for the three months ended MarchB 31, 2015 and 2014, respectively. These amounts are production waste and are not included in management's reserve for excess and obsolete inventory.
[2]	These amounts represent the reversal of reserves associated with inventory items that were sold during the period.

Recovered_Sheet1

Inventories, Net And Significant Suppliers - Purchases from Significant Suppliers (Details) (Cost of Goods, Total [Member], Supplier Concentration Risk [Member], USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015		Mar. 31, 2014
Victory Chemical [Member]
Concentration Risk [Line Items]
Inventory Purchases	$8,230		$0	[1]
Concentration risk	11.20%		0.00%	[1]
Maxim [Member]
Concentration Risk [Line Items]
Inventory Purchases	$0	[1]	$8,054
Concentration risk	0.00%	[1]	13.00%
[1]	Purchases from this supplier did not total more than 10% of our total inventory purchases in this period.

Inventories_Net_and_Significan4

Inventories, Net and Significant Suppliers - Related Party Vendor (Details) (USD $)	3 Months Ended	12 Months Ended	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014
Executive Vice President [Member]
Related Party Transaction [Line Items]
Ownership Percentage in Third Party by Executive	40.00%
Affiliated Entity [Member]
Related Party Transaction [Line Items]
Concentration Risk	3.30%	3.40%
Related Parties, Accounts Payable	2,131	$2,378
Supplier Concentration Risk [Member] | Cost of Goods, Total [Member] | Affiliated Entity [Member]
Related Party Transaction [Line Items]
Related Party Purchases	2,094		$1,723
Concentration Risk	2.90%		2.80%

Goodwill_and_Intangible_Assets2

Goodwill and Intangible Assets, Net - Goodwill (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015
Schedule of Goodwill
Goodwill, Opening balance	$30,739
FX effects	-214
Goodwill, Closing balance	$30,525

Goodwill_and_Intangible_Assets3

Goodwill and Intangible Assets, Net - Finite-Lived Intangibles (Details) (USD $)	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014	Dec. 31, 2014
Finite-Lived Intangible Assets, Net [Abstract]
Gross	$42,968,000	[1]		$42,643,000	[1]
Accumulated Amortization	-18,743,000	[1]		-18,029,000	[1]
Intangible assets, net	24,225,000			24,614,000
Finite-lived intangible assets, fully amortized, gross	8,200,000			7,900,000
Amortization expense	1,039,000		1,023,000
Cost of Sales [Member]
Finite-Lived Intangible Assets, Net [Abstract]
Amortization expense	35,000		37,000
Selling, General and Administrative Expenses [Member]
Finite-Lived Intangible Assets, Net [Abstract]
Amortization expense	1,004,000		986,000
Distribution rights
Finite-Lived Intangible Assets, Net [Abstract]
Gross	308,000	[1]		347,000	[1]
Accumulated Amortization	-74,000	[1]		-76,000	[1]
Intangible assets, net	234,000			271,000
Patents
Finite-Lived Intangible Assets, Net [Abstract]
Gross	10,471,000	[1]		10,107,000	[1]
Accumulated Amortization	-4,675,000	[1]		-4,736,000	[1]
Intangible assets, net	5,796,000			5,371,000
Trademark and trade names
Finite-Lived Intangible Assets, Net [Abstract]
Gross	2,001,000	[1]		2,001,000	[1]
Accumulated Amortization	-884,000	[1]		-834,000	[1]
Intangible assets, net	1,117,000			1,167,000
Developed and core technology
Finite-Lived Intangible Assets, Net [Abstract]
Gross	3,506,000	[1]		3,506,000	[1]
Accumulated Amortization	-1,432,000	[1]		-1,373,000	[1]
Intangible assets, net	2,074,000			2,133,000
Capitalized software development costs
Finite-Lived Intangible Assets, Net [Abstract]
Gross	276,000	[1]		276,000	[1]
Accumulated Amortization	-119,000	[1]		-85,000	[1]
Intangible assets, net	157,000			191,000
Customer relationships
Finite-Lived Intangible Assets, Net [Abstract]
Gross	26,406,000	[1]		26,406,000	[1]
Accumulated Amortization	-11,559,000	[1]		-10,925,000	[1]
Intangible assets, net	$14,847,000			$15,481,000
[1]	This table excludes the gross value of fully amortized intangible assets totaling $8.2 million and $7.9 million on MarchB 31, 2015 and DecemberB 31, 2014, respectively.

Goodwill_and_Intangible_Assets4

Goodwill and Intangible Assets, Net - Future Amortization Expense (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Schedule of Estimated Future Amortization expense
2015 (remaining 9 months)	$3,094
2016	4,077
2017	3,992
2018	3,973
2019	3,973
Thereafter	5,116
Intangible assets, net	$24,225	$24,614

Line_of_Credit_Details

Line of Credit (Details) (USD $)	0 Months Ended
	Oct. 09, 2014	Mar. 31, 2015
Line of Credit [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity	55,000,000
Line of Credit [Member] | US Bank [Member] | London Interbank Offered Rate (LIBOR) [Member] | Minimum [Member]
Line of Credit Facility [Line Items]
Basis spread on variable rate	1.25%
Line of Credit [Member] | US Bank [Member] | London Interbank Offered Rate (LIBOR) [Member] | Maximum [Member]
Line of Credit Facility [Line Items]
Basis spread on variable rate	1.75%
Line of Credit [Member] | US Bank [Member] | Base Rate [Member] | Minimum [Member]
Line of Credit Facility [Line Items]
Basis spread on variable rate	0.00%
Line of Credit [Member] | US Bank [Member] | Base Rate [Member] | Maximum [Member]
Line of Credit Facility [Line Items]
Basis spread on variable rate	0.50%
Line of Credit [Member] | US Bank [Member] | Enson [Member]
Line of Credit Facility [Line Items]
Subsidiary ownership percentage securing facility	65.00%
Letter of Credit [Member]
Line of Credit Facility [Line Items]
Letter of credit outstanding amount		$13,000

Income_Taxes_Details

Income Taxes (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
Income Taxes [Line Items]
Income tax expense (benefit)	$1,254,000	$1,352,000
Effective tax rate	19.50%	24.00%
Unrecognized tax benefits	3,700,000
Unrecognized tax benefits that would impact effective rate	3,200,000
Decrease in unrecognized tax benefits is reasonably possible in next 12 months	500,000
Accrued interest and penalties	200,000		200,000
China
Income Taxes [Line Items]
Income tax refund, research and development	$300,000

Accrued_Compensation_Details

Accrued Compensation (Details) (USD $)	Mar. 31, 2015		Dec. 31, 2014
Components of Accrued Compensation
Accrued social insurance	$19,898,000	[1]	$19,941,000	[1]
Accrued salary/wages	7,073,000		6,114,000
Accrued vacation/holiday	2,596,000		2,222,000
Accrued bonus	1,787,000	[2]	8,492,000	[2]
Accrued commission	386,000		1,797,000
Accrued medical insurance claims	309,000		236,000
Other accrued compensation	2,170,000		1,854,000
Total accrued compensation	34,219,000		40,656,000
Accrued salaries - 13th month salaries	$300,000		$600,000
[1]	Effective JanuaryB 1, 2008, the Chinese Labor Contract Law was enacted in the PRC. This law mandated that PRC employers remit the applicable social insurance payments to their local government. Social insurance is comprised of various components such as pension, medical insurance, job injury insurance, unemployment insurance, and a housing assistance fund, and is administered in a manner similar to social security in the United States. This amount represents our estimate of the amounts due to the PRC government for social insurance on MarchB 31, 2015 and DecemberB 31, 2014.
[2]	Accrued bonus includes an accrual for an extra month of salary ("13th month salary") to be paid to employees in certain geographies where it is the customary business practice. This 13th month salary is paid to these employees if they remain employed with us through DecemberB 31st. The total accrued for the 13th month salary was $0.3 million and $0.6 million at MarchB 31, 2015 and December 31, 2014, respectively.

Other_Accrued_Expenses_Details

Other Accrued Expenses (Details) (USD $)	Mar. 31, 2015		Dec. 31, 2014
In Thousands, unless otherwise specified
Payables and Accruals [Abstract]
Advertising and marketing	$156		$174
Deferred revenue	766		648
Duties	801		947
Freight and handling fees	1,976		1,522
Product development	518		751
Product warranty claim costs	173		353
Professional fees	1,713		1,493
Sales taxes and VAT	1,666		2,057
Third-party commissions	581		553
Tooling	648	[1]	1,089	[1]
Unrealized loss on foreign currency exchange futures contracts	57		113
Utilities	313		275
Other	3,038		3,383
Total other accrued expenses	$12,406		$13,358
[1]	The tooling accrual balance relates to unearned revenue for tooling that will be sold to customers.

Commitments_and_Contingencies_1

Commitments and Contingencies - Warranty (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Schedule of Changes in Reserve for Product Warranty Claim Costs
Balance at beginning of period	$353	$41
Accruals for warranties issued during the period	0	21
Settlements (in cash or in kind) during the period	-180	-41
Balance at end of period	$173	$21

Commitments_and_Contingencies_2

Commitments and Contingencies - Gain Contingencies (Details) (Patent Lawsuit Against Universal Remote Control [Member], Positive Outcome of Litigation [Member])	0 Months Ended				1 Months Ended	2 Months Ended
	Dec. 16, 2014	Jun. 28, 2013	Feb. 01, 2013	Mar. 02, 2012	Mar. 31, 2014	Jan. 31, 2015
	Patent	patent	claim	patent	patent	patent
			patent
Gain Contingencies [Line Items]
Gain contingency, patents allegedly infringed upon, number	1	10	4	4
Gain contingency, claims deemed invalid, number			4
Gain contingency, claims against defendant, number			24
Gain contingency, patents found not infringed upon, number			1		2
All Claims Accepted for Review by USPTO [Member]
Gain Contingencies [Line Items]
Gain contingency, patents allegedly infringed upon, number						5
Certain Claims Accepted for Review by USPTO [Member]
Gain Contingencies [Line Items]
Gain contingency, patents allegedly infringed upon, number						2
All Claims Denied for Review by USPTO [Member]
Gain Contingencies [Line Items]
Gain contingency, patents found valid, number						3
Total Claims Accepted for Review by USPTO [Member]
Gain Contingencies [Line Items]
Gain contingency, patents allegedly infringed upon, number						7

Commitments_and_Contingencies_3

Commitments and Contingencies - Loss Contingencies (Details) (USD $)	Mar. 10, 2015	Jan. 27, 2015
In Millions, unless otherwise specified
Loss Contingencies [Line Items]
Loss Contingency, Range of Possible Loss, Maximum	$5.70	$0.20

Treasury_Stock_Details

Treasury Stock (Details) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Apr. 29, 2015
Class of Stock [Line Items]
Shares repurchased	69,460	11,112
Cost of shares repurchased	$4,021	$405
Treasury stock reissued (shares)		7,500
Shares available for repurchase	998,195
Subsequent Event [Member]
Class of Stock [Line Items]
Stock repurchase program, additional number of shares authorized to be repurchased			101,805
Stock repurchase program, number of shares authorized to be repurchased			1,100,000

Business_Segment_and_Foreign_O2

Business Segment and Foreign Operations (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Schedule of Revenues from Geographical Segments [Line Items]
Total net sales	$132,705	$129,845
United States [Member]
Schedule of Revenues from Geographical Segments [Line Items]
Total net sales	54,759	47,896
Asia (excluding PRC) [Member]
Schedule of Revenues from Geographical Segments [Line Items]
Total net sales	31,020	31,518
People's Republic of China [Member]
Schedule of Revenues from Geographical Segments [Line Items]
Total net sales	15,836	20,670
Europe [Member]
Schedule of Revenues from Geographical Segments [Line Items]
Total net sales	15,022	15,271
Latin America [Member]
Schedule of Revenues from Geographical Segments [Line Items]
Total net sales	10,522	9,025
All Other Countries [Member]
Schedule of Revenues from Geographical Segments [Line Items]
Total net sales	$5,546	$5,465

Business_Segment_and_Foreign_O3

Business Segment and Foreign Operations - Long-lived Assets (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Long-lived Assets from External Customers and Long-Lived Assets [Line Items]
Long-lived tangible assets	$84,831	$81,606
United States [Member]
Long-lived Assets from External Customers and Long-Lived Assets [Line Items]
Long-lived tangible assets	5,631	5,716
People's Republic of China [Member]
Long-lived Assets from External Customers and Long-Lived Assets [Line Items]
Long-lived tangible assets	74,563	70,619
All Other Countries [Member]
Long-lived Assets from External Customers and Long-Lived Assets [Line Items]
Long-lived tangible assets	$4,637	$5,271

StockBased_Compensation_Expens

Stock-Based Compensation - Expense (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation	$1,959	$1,678
Income tax benefit	560	490
Cost of Sales [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation	9	4
Research and development [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation	105	101
Employees [Member] | Selling, general and administrative [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation	1,471	1,358
Outside Directors [Member] | Selling, general and administrative [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation	$374	$215

StockBased_Compensation_Option

Stock-Based Compensation - Option Activity (Details) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2015
Number of Options
Outstanding at December 31, 2014	650
Granted	74
Exercised	-39
Forfeited/canceled/expired	-7
Outstanding at March 31, 2015	678
Vested and expected to vest at March 31, 2015	678
Exercisable on March 31, 2015	449
Weighted-Average Exercise Price
Outstanding at December 31, 2014	$25.56
Granted	$65.54
Exercised	$25.60
Forfeited/canceled/expired	$21.54
Outstanding at March 31, 2015	$29.94
Vested and expected to vest at March 31, 2015	$29.95
Exercisable on March 31, 2015	$24.58
Weighted-Average Remaining Contractual Term and Aggregate Intrinsic Value
Outstanding at March 31, 2015	4 years 11 months 8 days
Vested and expected to vest at March 31, 2015	4 years 11 months 8 days
Exercisable on March 31, 2015	4 years 11 months 26 days
Exercised	$1,205
Outstanding at March 31, 2015	18,647	[1]
Vested and expected to vest at March 31, 2015	18,633	[1]
Exercisable on March 31, 2015	$14,318	[1]
[1]	The aggregate intrinsic value represents the total pre-tax value (the difference between our closing stock price on the last trading day of the first quarter of 2015 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had they all exercised their options on MarchB 31, 2015. This amount will change based on the fair market value of our stock.

StockBased_Compensation_Valuat

Stock-Based Compensation - Valuation Assumptions (Details) (USD $)	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Weighted average fair value of grants	$24.77	[1]	$13.64	[1]
Risk-free interest rate	1.38%		1.29%
Expected volatility	43.50%		44.84%
Expected life in years	4 years 6 months 21 days		4 years 6 months 21 days
[1]	The weighted average fair value of grants was calculated utilizing the stock options granted during each respective period.

Stockbased_Compensation_Detail

Stock-based Compensation (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total Compensation Cost Not yet Recognized	$3.40
Total Compensation Cost Not yet Recognized, Period for Recognition	2 years 2 months 12 days
Non-vested restricted stock award [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total Compensation Cost Not yet Recognized	$9.90
Total Compensation Cost Not yet Recognized, Period for Recognition	2 years 3 months 17 days

StockBased_Compensation_Restri

Stock-Based Compensation - Restricted Stock Activity (Details) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2015
Shares Granted
Non-vested at beginning of period	266
Shares granted	29
Shares Vested	-38
Shares Forfeited	0
Non-vested at end of period	257
Weighted-Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value Non-vested at beginning of period	$39.28
Weighted-Average Grant Date Fair Value Granted	$65.53
Weighted-Average Grant Date Fair Value Vested	$33.04
Weighted-Average Grant Date Fair Value Forfeited	$0
Weighted-Average Grant Date Fair Value Non-vested at end of period	$43.13

Other_Income_Expense_Net_Detai

Other Income (Expense), Net (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015		Mar. 31, 2014
Other Income and Expenses [Abstract]
Net gain (loss) on foreign currency exchange contracts	$1,034	[1]	($1,049)	[1]
Net gain (loss) on foreign currency exchange transactions	-854		693
Other income (expense)	50		7
Other income (expense), net	$230		($349)
[1]	This represents the gains and (losses) incurred on foreign currency hedging derivatives (see Note 16 for further details).

Earnings_Per_Share_Details

Earnings Per Share (Details) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
BASIC
Net income	$5,189	$4,273
Weighted-average common shares outstanding (in shares)	15,907	15,787
Basic earnings per share (in dollars per share)	$0.33	$0.27
DILUTED
Net income	$5,189	$4,273
Weighted-average common shares outstanding (in shares)	15,907	15,787
Dilutive effect of stock options and restricted stock (in shares)	336	376
Weighted-average common shares outstanding on a diluted basis (in shares)	16,243	16,163
Diluted earnings per share (in dollars per share)	$0.32	$0.26

Earnings_Per_Share_Antidilutiv

Earnings Per Share - Antidilutive Shares (Details)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Stock options and restricted stock excluded in computation of diluted earning per share	40	73
Restricted stock awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Stock options and restricted stock excluded in computation of diluted earning per share	16	28

Derivatives_Details

Derivatives (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015		Mar. 31, 2014
Derivative Instruments,Gain (Loss) [Line Items]
Maximum Remaining Maturity of Foreign Currency Derivatives	9 months
Net gain (loss) on foreign currency exchange contracts	$1,034	[1]	($1,049)	[1]
Not Designated as Hedging Instrument [Member] | Foreign Exchange Forward [Member] | Other Income (Expense), Net [Member]
Derivative Instruments,Gain (Loss) [Line Items]
Net gain (loss) on foreign currency exchange contracts	$1,034		($1,049)
[1]	This represents the gains and (losses) incurred on foreign currency hedging derivatives (see Note 16 for further details).

Derivatives_Fair_Value_Details

Derivatives - Fair Value (Details) (Fair Value, Measurements, Recurring [Member], Foreign Exchange Forward [Member], Not Designated as Hedging Instrument [Member], USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Estimate of Fair Value Measurement
Derivatives, Fair Value [Line Items]
Foreign currency exchange futures contracts fair value	$460	$810
Level 1 [Member]
Derivatives, Fair Value [Line Items]
Foreign currency exchange futures contracts fair value	0	0
Level 2 [Member]
Derivatives, Fair Value [Line Items]
Foreign currency exchange futures contracts fair value	460	810
Level 3 [Member]
Derivatives, Fair Value [Line Items]
Foreign currency exchange futures contracts fair value	$0	$0

Derivatives_Contracts_Held_Det

Derivatives - Contracts Held (Details) (Not Designated as Hedging Instrument [Member], Foreign Exchange Forward [Member], USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2015		Dec. 31, 2014
Euro
Derivative [Line Items]
Notional Value	$5,000,000		$5,000,000
Forward Rate	1.0989		1.245
Gain/(Loss) Recorded at Balance Sheet Date	110,000	[1]	140,000	[1]
Chinese Yuan Renminbi
Derivative [Line Items]
Notional Value	22,500,000		20,000,000
Forward Rate	6.2645		6.2757
Gain/(Loss) Recorded at Balance Sheet Date	-57,000	[1]	174,000	[1]
Future Contract One [Member] | Brazil, Brazil Real
Derivative [Line Items]
Notional Value	2,500,000		5,000,000
Forward Rate	2.769		2.3401
Gain/(Loss) Recorded at Balance Sheet Date	407,000	[1]	609,000	[1]
Future Contract Two [Member] | Brazil, Brazil Real
Derivative [Line Items]
Notional Value			2,500,000
Forward Rate			2.5442
Gain/(Loss) Recorded at Balance Sheet Date			($113,000)	[1]
[1]	Gains on futures contracts are recorded in prepaid expenses and other current assets. Losses on futures contracts are recorded in other accrued expenses.